Relationships among Parvalbumin-Immunoreactive Neuron Density, Phase-Locked Gamma Oscillations, and Autistic/Schizophrenic Symptoms in PDGFR-β Knock-Out and Control Mice

Animal Models of Autism Spectrum Disorder (ASD): A Synaptic-Level Approach to Autistic-Like Behavior in Mice

(2013) Yo SHINODA et al.   EXPERIMENTAL ANIMALS

Distinct Dendritic Arborization and In Vivo Firing Patterns of Parvalbumin-Expressing Basket Cells in the Hippocampal Area CA3

(2013) J. J. Tukker et al.   JOURNAL OF NEUROSCIENCE

Effects of the neurotrophic agent T-817MA on oligomeric amyloid-β–induced deficits in long-term potentiation in the hippocampal CA1 subfield

(2013) Yusaku Takamura et al.   NEUROBIOLOGY OF AGING

Aberrant neural synchrony in the maternal immune activation model: using translatable measures to explore targeted interventions

(2013) Desiree D. Dickerson et al.   Frontiers in Behavioral Neuroscience

Reduced Natural Oscillatory Frequency of Frontal Thalamocortical Circuits in Schizophrenia

(2012) Fabio Ferrarelli et al.   ARCHIVES OF GENERAL PSYCHIATRY

Mice with reduced NMDA receptor expression: more consistent with autism than schizophrenia?

(2012) M. J. Gandal et al.   GENES BRAIN AND BEHAVIOR

The molecular basis of cognitive deficits in pervasive developmental disorders

(2012) A. Bhattacharya et al.   LEARNING & MEMORY

MeCP2+/− mouse model of RTT reproduces auditory phenotypes associated with Rett syndrome and replicate select EEG endophenotypes of autism spectrum disorder

(2012) Wenlin Liao et al.   NEUROBIOLOGY OF DISEASE

Update: Studies of prepulse inhibition of startle, with particular relevance to the pathophysiology or treatment of Tourette Syndrome

(2012) Neal R. Swerdlow   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

GABAergic Circuit Dysfunctions in Neurodevelopmental Disorders

(2012) Bidisha Chattopadhyaya et al.   Frontiers in Psychiatry

T-817MA, a neuroprotective agent, attenuates the motor and cognitive impairments associated with neuronal degeneration in P301L tau transgenic mice

(2011) Tetsuo Fukushima et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Animal models of schizophrenia

(2011) CA Jones et al.   BRITISH JOURNAL OF PHARMACOLOGY

A critical role for NMDA receptors in parvalbumin interneurons for gamma rhythm induction and behavior

(2011) M Carlén et al.   MOLECULAR PSYCHIATRY

Neocortical excitation/inhibition balance in information processing and social dysfunction

(2011) Ofer Yizhar et al.   NATURE

Dendritic spine pathology in neuropsychiatric disorders

(2011) Peter Penzes et al.   NATURE NEUROSCIENCE

Dual Mechanism of Neuronal Ensemble Inhibition in Primary Auditory Cortex

(2011) Monica N. O'Connell et al.   NEURON

Gamma synchrony: Towards a translational biomarker for the treatment-resistant symptoms of schizophrenia

(2011) Michael J. Gandal et al.   NEUROPHARMACOLOGY

Cognitive and Socio-Emotional Deficits in Platelet-Derived Growth Factor Receptor-β Gene Knockout Mice

(2011) Phuong Thi Hong Nguyen et al.   PLoS One

Validating γ Oscillations and Delayed Auditory Responses as Translational Biomarkers of Autism

(2010) Michael J. Gandal et al.   BIOLOGICAL PSYCHIATRY

Stable Mossy Fiber Long-Term Potentiation Requires Calcium Influx at the Granule Cell Soma, Protein Synthesis, and Microtubule-Dependent Axonal Transport

(2010) S. J. Barnes et al.   JOURNAL OF NEUROSCIENCE

Animal models of neuropsychiatric disorders

(2010) Eric J Nestler et al.   NATURE NEUROSCIENCE

Cognitive Control Deficits in Schizophrenia: Mechanisms and Meaning

(2010) Tyler A Lesh et al.   NEUROPSYCHOPHARMACOLOGY

Parvalbumin-, calbindin-, and calretinin-immunoreactive hippocampal interneuron density in autism

(2009) Y. A. Lawrence et al.   ACTA NEUROLOGICA SCANDINAVICA

T-817MA, a neurotrophic agent, ameliorates the deficits in adult neurogenesis and spatial memory in rats infused i.c.v. with amyloid-β peptide

(2009) Tatsuo Kimura et al.   BRITISH JOURNAL OF PHARMACOLOGY

Common circuit defect of excitatory-inhibitory balance in mouse models of autism

(2009) Nadine Gogolla et al.   Journal of Neurodevelopmental Disorders

Parvalbumin neurons and gamma rhythms enhance cortical circuit performance

(2009) Vikaas S. Sohal et al.   NATURE

The Leading Sense: Supramodal Control of Neurophysiological Context by Attention

(2009) Peter Lakatos et al.   NEURON

Does schizophrenia arise from oxidative dysregulation of parvalbumin-interneurons in the developing cortex?

(2009) M. Margarita Behrens et al.   NEUROPHARMACOLOGY

Prefrontal GABAB Receptor Activation Attenuates Phencyclidine-Induced Impairments of Prepulse Inhibition: Involvement of Nitric Oxide

(2009) Kim Fejgin et al.   NEUROPSYCHOPHARMACOLOGY

Serum levels of platelet-derived growth factor BB homodimers are increased in male children with autism

(2009) Masanobu Kajizuka et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

The Early Auditory Gamma-Band Response Is Heritable and a Putative Endophenotype of Schizophrenia

(2009) M.-H. Hall et al.   SCHIZOPHRENIA BULLETIN

Modeling the Positive Symptoms of Schizophrenia in Genetically Modified Mice: Pharmacology and Methodology Aspects

(2009) M. van den Buuse   SCHIZOPHRENIA BULLETIN

A neuroprotective agent, T-817MA (1-{3-[2-(1-benzothiophen-5-yl)ethoxy]propyl} azetidin-3-ol maleate), prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in mice

(2008) Toshiyuki Kawasaki et al.   NEUROPHARMACOLOGY

Sensory gating in young children with autism: Relation to age, IQ, and EEG gamma oscillations

(2008) Elena V. Orekhova et al.   NEUROSCIENCE LETTERS

Event-Related EEG Time-Frequency Analysis: An Overview of Measures and An Analysis of Early Gamma Band Phase Locking in Schizophrenia

(2008) B. J. Roach et al.   SCHIZOPHRENIA BULLETIN

Genetic association between 5′-upstream single-nucleotide polymorphisms of PDGFRB and schizophrenia in a Korean population

(2008) Hak-Jae Kim et al.   SCHIZOPHRENIA RESEARCH

High-field MRS study of GABA, glutamate and glutamine in social anxiety disorder: Response to treatment with levetiracetam

(2007) Mark H. Pollack et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY